Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport
Detection Principle
NucleicAcid-PCR based
Target
RdRP (Abbott ID Now), N2, E (Cepheid Xpert)
Testing Method Category
PCR_KIT
Testing Method
kits (Abbot ID Now, Cepheid Xpert)
Testing Method - Additional Info
Comparisons between Abbott ID Now COVID-19 and Cepheid Xpert Xpress SARS-CoV-2
Reported Performance
PPA: 54.8% (using dry nasal swabs fro ID Now); NPA: 98.6% (using dry nasal swabs fro ID Now); overall agreement: 85.1%; PPV:94.4%; NPV: 83.1%
Sample Size
101 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements